{
    "2019-10-29": [
        [
            {
                "time": "2018-10-30",
                "original_text": "Will Opdivo & Eliquis Drive Bristol-Myers (BMY) Q3 Earnings?",
                "features": {
                    "keywords": [
                        "Opdivo",
                        "Eliquis",
                        "Bristol-Myers",
                        "Q3 Earnings"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-10-31",
                "original_text": "Incyte (INCY) Beats on Q3 Earnings & Sales, Ups Jakafi View",
                "features": {
                    "keywords": [
                        "Incyte",
                        "Q3 Earnings",
                        "Sales",
                        "Jakafi"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}